View All Key Stats
CERS Key Stats
| Income Statement | |
| Revenue (TTM) | 40.08M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.63 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -64.64M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 56.20% |
| Profit Margin (Quarterly) | -220.5% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 242.22M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 5.928 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 5.839 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.4377 |
| Free Cash Flow (Quarterly) | -16.53M |
| Return on Equity (TTM) | -98.01% |
View All CERS News
CERS News
-
WireHeadlineTime (ET)
-
MT Newswires07/27 12:58
-
SA Breaking News07/27 12:47
-
SA Breaking News07/27 12:42
-
SA Breaking News07/27 11:01
-
Business Wire07/27 08:30
-
Business Wire07/21 08:30
-
Yahoo07/11 14:17
-
Business Wire06/21 08:30
-
Yahoo06/08 08:00
-
SA Breaking News06/07 14:46
View All Events
CERS Events
| Date | Type | Description |
|---|---|---|
| 08/03/2017 16:15 EDT | Misc | Cerus Corp Second Quarter Earnings Conference Call in 2017 |
| 08/03/2017 | Earnings | Cerus Corp Second Quarter Earnings in 2017 Release |
| 06/07/2017 | Misc | Cerus Corp Annual General Meeting in 2016 |
| 05/03/2017 16:15 EDT | Misc | Cerus Corp First Quarter Earnings Conference Call in 2017 |
| 05/03/2017 | Earnings | Cerus Corp First Quarter Earnings in 2017 Release |
| 03/07/2017 16:15 EST | Misc | Cerus Corp Fourth Quarter Earnings Conference Call in 2016 |
| 03/07/2017 | Earnings | Cerus Corp Fourth Quarter Earnings in 2016 Release |
| 11/03/2016 16:15 EDT | Misc | Cerus Corp Third Quarter Earnings Conference Call in 2016 |
| 11/03/2016 | Earnings | Cerus Corp Third Quarter Earnings in 2016 Release |
| 08/04/2016 16:15 EDT | Misc | Cerus Corp Second Quarter Earnings Conference Call in 2016 |
CERS Fundamentals
Income Statement View Statement
CERS Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
CERS One Page Reports
- One Page Report Download
CERS Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 2.31 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.cerus.com
- Investor Relations URL: N/A
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: Aug. 03, 2017
- Last Earnings Release: May. 03, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.
CERS Comparables
EditCERS Excel Add-In Codes
- Name: =YCI("CERS","name")
- Description: =YCI("CERS","description")
- Sector: =YCI("CERS","sector")
- Industry: =YCI("CERS","industry")
- Est. Current Fiscal Year End: =YCI("CERS","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other CERS Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CERS Tweets Stocktwits
Advertisement
